Skip to main content
. 2022 Apr 29;44(3):1373–1392. doi: 10.1007/s11357-022-00556-w

Fig. 3.

Fig. 3

Difference in blood C-reactive protein levels between subjects with vascular dementia and controls (A) or those with Alzheimer’s disease (B); pooled hazard ratios for C-reactive protein and incident vascular dementia (C)